Everyone knows Ozempic and Wegovy for one reason: weight loss. But in 2026, a wave of new research is revealing something that is catching even doctors off guard. These GLP-1 receptor agonist drugs are doing far more than shrinking waistlines – they are reducing migraines, lowering blood pressure, protecting the heart, and now showing promise […]
Weight loss surgery dominated obesity treatment for over two decades. Surgeons could not keep up with demand. Hospital waiting lists stretched months long. Then, almost overnight, the operating rooms started getting quieter. The reason is sitting in millions of medicine cabinets. GLP-1 drugs — Ozempic, Wegovy, Mounjaro, Zepbound — have surged so dramatically that bariatric […]
A luxury cruise ship has become the center of a global health alert. On May 2, 2026, the World Health Organization issued an emergency disease outbreak notice after a cluster of hantavirus infections was detected among passengers of the Dutch-flagged expedition vessel MV Hondius. Eight people have been infected. Three have died. The culprit: the […]
Dementia affects over 55 million people worldwide — and that number is projected to nearly triple by 2050. In India alone, more than 8 million people are currently living with some form of dementia, with Alzheimer’s disease being the most common. Yet a landmark statement from the American Heart Association, backed by decades of research, […]
A new weight loss drug is generating some of the most striking clinical trial results ever seen in the field of obesity medicine. Survodutide — developed by Boehringer Ingelheim and Zealand Pharma — produced weight loss of up to 19 percent in early-phase trials, with its phase 3 programme now underway. For a field that […]
